Point72 Hong Kong LTD Athira Pharma, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $5,408 - $7,310	1,846 New	1,846 $5,000
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $3,246 - $5,802	-354 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $28,072 - $34,024	-3,068 Reduced 89.66%	354 $3,000
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $35,041 - $71,417	3,422 New	3,422 $35,000
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $176,055 - $366,426	-10,683 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $171,141 - $197,208	10,683 New	10,683 $197,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $22.3M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.